Why Hardware Innovation Takes a Decade (Not Two Years)

In early 2021, my co-founders Nick Potter and Tom Faggionato and I set out to raise capital for a breathing wellness device called exhalo. Five years later, it's worth examining not whether we were right about the opportunity, but whether we understood the timeline required to capture it.

The timing looked perfect. We were in the middle of COVID, and breathing had become urgent in ways it never had been before. Lockdowns created epidemic levels of stress and anxiety. People were searching for home wellness solutions that could provide genuine support with proper medical evidence. The breathing wellness category was emerging fast - Breathwrk had reached the Top 10 Health & Fitness apps by mid-2020, and other platforms were gaining traction.

The problem we were solving was real and substantial. Dysfunctional breathing affects 6-12% of the general population - rising to 29-34% among asthmatics. Chronic stress causes people to hold their breath, hyperventilate, or breathe shallowly from the chest rather than the diaphragm. These poor breathing patterns drive cascading health problems: anxiety, insomnia, hypertension, chronic back pain, IBS, even bone density issues.

Our medical advisory board included leading consultants in respiratory medicine, cardiology, and psychiatry. Our approach was evidence-based. The product - a discreet wearable that tracked breathing patterns and vibrated to nudge users toward proper diaphragmatic breathing - addressed something no other device was measuring correctly.

We spent a year working through investor conversations. By early 2022, it became clear we weren't going to raise the capital needed.

Why Apps Won and Hardware Didn't

The market was forming exactly as we'd predicted. But we were building the wrong type of solution for the timeline investors required.

Apps could scale immediately. Breathwrk launched in November 2019 and reached Top 10 status within months. Othership launched in December 2021 - right as we were fundraising - as a breathwork-first platform. The market grew from roughly $100 million in 2021 to an estimated $1.2 billion by 2025. That's twelve-fold growth in four years.

Software required no manufacturing complexity, no inventory risk, no regulatory pathway, and offered the margins investors expected from digital products. The breathing wellness category was validated, capital was flowing, and apps were capturing it.

Hardware required everything investors didn't want. Manufacturing complexity. Long development cycles. Regulatory certification pathways. Lower margins. Inventory risk. And most critically, a much longer timeline from investment to revenue.

The London venture capital environment in 2021 - more conservative than Silicon Valley, more skeptical of hardware - had watched breathing apps prove the market. Why fund a hardware solution when software was already winning?

We understood the objections. What we misjudged was whether investors would value solving the problem correctly over solving it quickly.

What Software Couldn't Actually Solve

Five years later, the breathing wellness market has matured substantially. Consumer awareness is higher. Medical validation is stronger. The category is established. Major technology companies have entered the space - Apple Watch added Breathing Disturbances measurement, Garmin integrated Respiration Rate tracking, WHOOP launched stress-relieving breathwork protocols in March 2023.

But every solution tracks breathing from the wrist. Apple Watch uses an accelerometer to detect micro-movements. Garmin and WHOOP derive respiration rate from Heart Rate Variability data. These are proxy measurements. They track breathing outcomes - rate, disturbances, patterns during sleep - but they cannot measure breathing mechanics.

They cannot detect breath-holding. They cannot identify hyperventilation. They cannot distinguish diaphragmatic breathing from shallow chest breathing. And they certainly cannot intervene in real time when someone's stress response triggers poor breathing patterns during a meeting, on a call, or in the middle of a crisis.

The exhalo Nudge was designed to sit on the abdomen precisely because that's where breathing actually happens. Diaphragmatic movement, breath depth, holding patterns - these can only be measured accurately at the torso, not the wrist. Our device tracked six biomarkers and vibrated the moment it detected poor breathing, creating an immediate feedback loop: you feel the vibration, you take control, you consciously breathe.

That specific innovation - accurate abdominal measurement combined with real-time intervention - still doesn't exist in the consumer market. Software validated that breathing wellness is a billion-pound opportunity. But software fundamentally cannot solve the measurement problem we identified.

The Hardware Timeline Nobody Wants to Fund

Hardware innovation operates on a different clock than software innovation.

I've seen this pattern repeatedly. A company I advised, MysteryVibe, solved a genuine problem in sexual health with an innovative hardware solution. It took more than ten years to see meaningful commercial results, despite having the right product and the right market. Hardware manufacturing, regulatory pathways, distribution channels, customer education - each stage takes longer than investors expect and founders anticipate.

Software can validate a market in two years. Hardware takes a decade to capture it.

What I learned subsequently about hardware innovation is that it succeeds when it's software-enabled rather than hardware-first. The most successful hardware solutions in recent years haven't been better devices - they've been devices that become platforms for software interaction. The hardware creates the data infrastructure. The software creates the value and the business model.

This changes the investment thesis entirely. Pure hardware requires capital patience that most venture investors don't have. Software-enabled hardware can show traction faster, iterate on the software layer while the hardware stabilizes, and build sustainable business models that justify the longer development cycle.

What This Means for Innovation Timing

In 2021, we had the right problem, the right solution, and the right market validation. What we didn't have was the right funding structure for hardware innovation.

If we'd structured exhalo as a software-first company - launched the app, built the breathing content library, established the brand, gathered user data - we might have raised capital easily. Then we could have introduced the hardware as a premium add-on once the software had proven traction.

But we believed the hardware was essential from day one. And we were right about that. The apps that have succeeded in breathing wellness provide guided exercises and content. They don't - because they can't - measure and correct subconscious breathing patterns in real time. The innovation we identified still doesn't exist.

The question is not whether we were right about the opportunity. Five years of market development have confirmed that. The question is whether we understood the timeline required to capture it.

Hardware innovation takes longer than market validation. Software can prove a market exists. Hardware can solve the problem software can't. But hardware requires patient capital, structured staging, and realistic expectations about the timeline from investment to meaningful revenue.

For founders navigating similar situations - where the technical solution is clearly superior but requires hardware - the lesson is strategic. Validate with software first if possible. Use the software to prove the market, build the brand, gather data, and establish revenue before introducing the hardware that solves the problem completely. This matches the funding timeline to the development reality.

For investors evaluating hardware innovation, the lesson is different. If software is already validating the market but fundamentally cannot solve the core problem, the gap represents a genuine opportunity. But only if the investment horizon matches the hardware timeline.

Market validation and solution readiness operate on different clocks. Understanding which clock matters more - and when - determines whether you're too early, too late, or exactly right.

The breathing wellness market is now worth over a billion pounds. The problem exhalo set out to solve remains unsolved. The question is whether the timing is finally right to build it - and whether patient capital exists to fund hardware innovation on a hardware timeline.